Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | NOS3 | P29474 | 1/20 | 0.32 |
| ▸ | NOS1 | P29475 | 1/20 | 0.32 |
| ▸ | NOS2 | P35228 | 1/20 | 0.32 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17459591 | 0.87 | TLR4 (0.31) | MAPT | |
| SCHEMBL2691430 | 0.86 | MAPT (0.39) | MAPTNOS3NOS1NOS2LMNA | |
| SCHEMBL7758858 | 0.84 | CTSV (0.36) | — | |
| SCHEMBL27917131 | 0.83 | TRIM24 (0.44) | LMNACYP3A4GAACYP2C9CYP2C19 | |
| SCHEMBL11800760 | 0.83 | TRIM24 (0.40) | NOS1NOS2LMNACYP3A4GAA | |
| SCHEMBL11617811 | 0.80 | MAPT (0.34) | MAPT | |
| SCHEMBL11451870 | 0.79 | MAPT (0.30) | MAPT | |
| SCHEMBL9998072 | 0.79 | MAPT (0.30) | MAPT | |
| SCHEMBL2436083 | 0.77 | LMNA (0.33) | LMNA | |
| SCHEMBL11614859 | 0.77 | MAPT (0.33) | MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260068882-A1 | ARTHROPOD CONTROLLING COMPOSITION | FIRMENICH & CIE (CH) | 2026-03-12 | — | — | US | claimed |
| US-20230105693-A1 | ANTIMICROBIAL COMPOSITIONS | FIRMENICH SA (CH) | 2023-04-06 | — | — | US | claimed |
| EP-4106718-A1 | ANTIMICROBIAL COMPOSITIONS | Firmenich SA (CH) | 2022-12-28 | — | — | EP | claimed |
| US-20220142158-A1 | ARTHROPOD CONTROL COMPOSITIONS | FIRMENICH SA (CH) | 2022-05-12 | — | — | US | claimed |
| US-20220142157-A1 | ARTHROPOD CONTROLLING COMPOSITION | FIRMENICH SA (CH) | 2022-05-12 | — | — | US | claimed |
| CN-114096235-A | Antimicrobial compositions | 弗门尼舍有限公司 | 2022-02-25 | — | — | CN | claimed |
| CN-113905612-A | Arthropod control composition | 弗门尼舍有限公司 | 2022-01-07 | — | — | CN | claimed |
| EP-3930460-A1 | ARTHROPOD CONTROL COMPOSITIONS | Firmenich SA (CH) | 2022-01-05 | — | — | EP | claimed |
| EP-3930461-A1 | ARTHROPOD CONTROLLING COMPOSITION | Firmenich SA (CH) | 2022-01-05 | — | — | EP | claimed |
| CN-113873884-A | Arthropod control composition | 弗门尼舍有限公司 | 2021-12-31 | — | — | CN | claimed |
| WO-2020239980-A1 | ARTHROPOD CONTROLLING COMPOSITION | FIRMENICH SA (CH) | 2020-12-03 | — | — | WO | claimed |
| WO-2020239954-A1 | ARTHROPOD CONTROL COMPOSITIONS | FIRMENICH SA (CH) | 2020-12-03 | — | — | WO | claimed |
| EP-1073702-B1 | PERFUMES COMPRISING 4-ISOBUTYLCYCLOHEXANOLS | QUEST INT (NL) | 2002-10-16 | — | — | EP | claimed |
| US-20260068882-A1 | ARTHROPOD CONTROLLING COMPOSITION | FIRMENICH & CIE (CH) | 2026-03-12 | — | — | US | disclosed |
| US-12497577-B2 | Method of countering malodour in a washing machine comprising the addition of a fragrance precursor | GIVAUDAN SA (CH) | 2025-12-16 | — | — | US | disclosed |
| US-20250186646-A1 | Use of Volatile Compositions to Limit or Eliminate Perception of Fecal Malodour | FIRMENICH SA (CH) | 2025-06-12 | — | — | US | disclosed |
| EP-0612783-A1 | Cyanate resin composition and copper-clad laminate | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1994-08-31 | — | — | EP | disclosed |
| EP-0600084-A1 | INDOLE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-06-08 | — | — | EP | disclosed |
| WO-1993003012-A1 | INDOLE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-02-18 | — | — | WO | disclosed |
| US-4130502-A | Liquid crystalline cyclohexane derivatives | MERCK PATENT GESELLSCHAFT MIT (DE) | 1978-12-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260068882-A1 | ARTHROPOD CONTROLLING COMPOSITION | CNOT9, MSL1, MT-CO2 | MAPT 4191/4885NOS3 2415/4885NOS1 2790/4885 |
| US-20220142157-A1 | ARTHROPOD CONTROLLING COMPOSITION | AGO2, NOP2, FBL | MAPT 2538/4885NOS3 2878/4885NOS1 2880/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.